Applied Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $1,000 | $0 | $-1 | $0 |
Gross Profit | -9,923 | -7,837 | ||
EBITDA | -18,879 | -23,097 | -25,524 | |
EBIT | -18,990 | -23,098 | -25,525 | -33,022 |
Net Income | -18,990 | -21,330 | -21,825 | 44,007 |
Net Change In Cash | 1,000 | 0 | -1 | 0 |
Free Cash Flow | -18,401 | -20,341 | -28,636 | -19,469 |
Cash | 11,945 | 30,421 | 50,762 | 79,398 |
Basic Shares | 145,559 | 145,091 | 144,788 | 137,228 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $455 | $9,993 | $10,660 | $0 |
Gross Profit | -48,289 | -43,912 | -441 | -415 |
EBITDA | -104,298 | -64,534 | -82,067 | -105,203 |
EBIT | -104,299 | -64,535 | -82,508 | -105,618 |
Net Income | -105,624 | -119,763 | -82,508 | -104,614 |
Net Change In Cash | 455 | 9,993 | 10,660 | 0 |
Free Cash Flow | -84,305 | -55,173 | -78,093 | -90,728 |
Cash | 79,398 | 49,898 | 16,657 | 53,888 |
Basic Shares | 139,535 | 84,244 | 37,825 | 25,598 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.13 |
2025-06-30 | -$0.15 |
2025-03-31 | $0.32 |
2024-12-31 | $0.33 |
